March 1, 2017 / 1:29 PM / 6 months ago

BRIEF-Pacira Pharmaceuticals reports Q4 adj. earnings per share $0.09

March 1 (Reuters) - Pacira Pharmaceuticals Inc

* Pacira Pharmaceuticals reports 2016 financial results and provides business update

* Q4 non-GAAP earnings per share $0.09

* Q4 GAAP loss per share $0.11

* Q4 revenue $72.9 million versus I/B/E/S view $73.1 million

* Q4 earnings per share view $0.01 -- Thomson Reuters I/B/E/S

* Pacira Pharmaceuticals Inc sees FY 2017 exparel net product sales of $290 million to $310 million

* Sees 2017 exparel net product sales of $290 million to $310 million

* Pacira Pharmaceuticals Inc sees FY 2017 non-GAAP gross margins of approximately 70 pct Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below